These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2917313)

  • 1. Functional morbidity after regional isolated perfusion of the limb for melanoma.
    van Geel AN; van Wijk J; Wieberdink J
    Cancer; 1989 Mar; 63(6):1092-6. PubMed ID: 2917313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional morbidity of hyperthermic isolated regional perfusion of the extremities.
    Olieman AF; Schraffordt Koops H; Geertzen JH; Kingma H; Hoekstra HJ; Oldhoff J
    Ann Surg Oncol; 1994 Sep; 1(5):382-8. PubMed ID: 7850539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolated hyperthermia chemotherapy perfusion for limb melanoma.
    Krementz ET; Sutherland CM; Muchmore JH
    Surg Clin North Am; 1996 Dec; 76(6):1313-30. PubMed ID: 8977553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolated limb perfusion for unresectable melanoma of the extremities.
    Noorda EM; Vrouenraets BC; Nieweg OE; van Geel BN; Eggermont AM; Kroon BB
    Arch Surg; 2004 Nov; 139(11):1237-42. PubMed ID: 15545572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Isolated hyperthermic perfusion of extremities in malignant melanoma with melphalan and tumor necrosis factor].
    Kettelhack C; Hohenberger P; Schlag PM
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():127-9. PubMed ID: 9101810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeat isolated limb perfusion with TNFalpha and melphalan for recurrent limb melanoma after failure of previous perfusion.
    Noorda EM; Vrouenraets BC; Nieweg OE; van Geel AN; Eggermont AM; Kroon BB
    Eur J Surg Oncol; 2006 Apr; 32(3):318-24. PubMed ID: 16412605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeat isolated limb perfusion with melphalan for recurrent melanoma of the limbs.
    Klop WM; Vrouenraets BC; van Geel BN; Eggermont AM; Klaase JM; Nieweg OE; Kroon BB
    J Am Coll Surg; 1996 Jun; 182(6):467-72. PubMed ID: 8646345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term functional morbidity after mild hyperthermic isolated limb perfusion with melphalan.
    Vrouenraets BC; in't Veld GJ; Nieweg OE; van Slooten GW; van Dongen JA; Kroon BB
    Eur J Surg Oncol; 1999 Oct; 25(5):503-8. PubMed ID: 10529261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic hyperthermic limb perfusion in stage I melanoma.
    Krige JE; King HS; Strover RM
    Eur J Surg Oncol; 1988 Aug; 14(4):321-6. PubMed ID: 3044834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcome of hyperthermic isolated limb perfusion (HILP) in the treatment of locoregionally metastasised malignant melanoma of the extremities.
    Boesch CE; Meyer T; Waschke L; Merkel S; Goehl J; Hohenberger W; Knorr C
    Int J Hyperthermia; 2010 Feb; 26(1):16-20. PubMed ID: 20100048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolated limb perfusion for malignant melanoma.
    Rosin RD; Westbury G
    Practitioner; 1980 Oct; 224(1348):1031-6. PubMed ID: 7220430
    [No Abstract]   [Full Text] [Related]  

  • 12. Hyperthermic isolation limb perfusion with TNFalpha in the treatment of in-transit melanoma metastasis.
    Di Filippo F; Rossi CR; Santinami M; Cavaliere F; Garinei R; Anzà M; Perri P; Botti C; Di Angelo P; Pasqualoni R; Di Filippo S
    In Vivo; 2006; 20(6A):739-42. PubMed ID: 17203758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities--long-term follow-up of a randomised trial.
    Olofsson Bagge R; Mattsson J; Hafström L
    Int J Hyperthermia; 2014 Aug; 30(5):295-8. PubMed ID: 25144818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of age on outcomes after isolated limb perfusion for advanced extremity malignancies.
    Smith HG; Wilkinson MJ; Smith MJF; Strauss DC; Hayes AJ
    Eur J Cancer; 2018 Sep; 100():46-54. PubMed ID: 29940423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolated limb infusion with hyperthermia and chemotherapy for advanced limb malignancy: factors influencing toxicity.
    Duprat Neto JP; Mauro AC; Molina AS; Nishinari K; Zurstrassen CE; Costa OF; Belfort FA; Facure L; Fregnani JH
    ANZ J Surg; 2014 Sep; 84(9):677-82. PubMed ID: 22998400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour response after hyperthermic isolated limb perfusion for locally advanced melanoma.
    Paulsen IF; Chakera AH; Drejøe JB; Klyver H; Dahlstrøm K; Oturai PS; Mortensen J; Hesse B; Schmidt G; Drzewiecki K
    Dan Med J; 2014 Jan; 61(1):A4741. PubMed ID: 24393586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional isolated limb perfusion of melanoma intransit metastases using mechlorethamine (nitrogen mustard).
    Shiu MH; Knapper WH; Fortner JG; Yeh S; Horowitz G; Schnog J; Guerra J; Gould-Rossbach P; Ray C
    J Clin Oncol; 1986 Dec; 4(12):1819-26. PubMed ID: 3783205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of isolated perfusion of extremities for recurrent tumor in elderly patients.
    Ariyan S; Poo WJ
    Surgery; 1998 Mar; 123(3):335-43. PubMed ID: 9526527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperthermic isolated regional perfusion in the treatment of extremity melanoma in children and adolescents.
    Baas PC; Hoekstra HJ; Schraffordt Koops H; Oosterhuis WJ; van der Weele LT
    Cancer; 1989 Jan; 63(1):199-203. PubMed ID: 2910418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperthermic isolated limb perfusion with intra-arterial administration of carboplatin and/or interferon-beta for the treatment of malignant melanoma of the leg.
    Nakayama J; Takeuchi M; Mayumi H; Nagae S; Matsuda K; Yasui H; Takahashi S; Hori Y
    J Dermatol; 1994 Nov; 21(11):915-22. PubMed ID: 7852655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.